NEW YORK, July 26, 2011 /PRNewswire/ -- BNY Mellon, the global leader in investment management and investment services, has been selected by BioLineRx Ltd. as the depositary bank for its American depositary receipt (ADR) program. Each BioLineRx ADR represents 10 ordinary shares and trades on t
↧